Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

GHRP-6

Growth Hormone Releasing Peptide-6, Growth hormone-releasing hexapeptide, His-D-Trp-Ala-Trp-D-Phe-Lys-NH2

Quick Stats
Studies 702
Trials 0
Score 3
2011 pubmed 19 citations

Ghrelin postsynaptically depolarizes dorsal raphe neurons in rats in vitro.

Ogaya. Masaki M; Kim. Juhyon J; Sasaki. Kazuo K

Key Findings

  • Ghrelin depolarizes dorsal raphe neurons in a dose‑dependent way, even when sodium channels are blocked.
  • The effect is blocked by the GHS‑R antagonist [D‑Lys(3)]‑GHRP‑6, confirming it works through ghrelin receptors.
  • Depolarization involves a dual ionic mechanism: increased non‑selective cation conductance and reduced potassium conductance.
  • About 80% of recorded neurons are likely serotonergic, and ghrelin activates roughly 75% of these.

Practical Outcomes

  • For biohackers, this suggests that ghrelin‑based peptides (like GHRP‑6) could influence serotonin‑related functions such as mood, sleep, and appetite, beyond just growth hormone release. However, the data are from rat brain slices in vitro, so human effects, optimal dosing, and safety remain uncertain and require more research before practical protocols can be recommended.

Summary

The study shows that ghrelin, a hormone that boosts growth hormone and hunger, can directly activate brain cells in the dorsal raphe (a key serotonin hub) by making them more electrically active. This activation uses two ion pathways and is blocked by a specific ghrelin‑receptor blocker. Most of the responsive cells are likely serotonin‑producing, linking ghrelin to mood, sleep, and feeding control.

Abstract

Ghrelin promotes growth hormone (GH) secretion and feeding. Recent studies further showed that ghrelin displayed a defending effect against the depressive-like symptoms and affected sleep in animals and humans. Serotonergic system is considered to be implicated in feeding, depression and other mood disorders, and sleep. The dorsal raphe nucleus (DRN) utilizes serotonin (5-HT) as its major neurotransmitter and expresses GH secretagogue receptors (GHS-Rs). Therefore, the present study was carried out to examine the electrophysiological effect of ghrelin on rat DRN neurons in vitro and determine the ionic mechanism involved. Whole-cell recording revealed that ghrelin depolarized DRN neurons dose-dependently in tetrodotoxin-containing artificial cerebrospinal fluid (TTX ACSF). Pretreatment with [D-Lys(3)]-GHRP-6, a selective antagonist for GHS-Rs, antagonized the ghrelin-induced depolarization. The depolarization was significantly reduced in a low-Na(+) TTX ACSF and in a high-K(+) TTX ACSF and was abolished in the combination of both ACSFs, suggesting that the ghrelin-induced depolarization is mediated by a dual ionic mechanism including an increase in nonselective cationic conductance and a decrease in K(+) conductance. The experiments on the reversal potential also supported an involvement of the dual ionic mechanism in the ghrelin-induced depolarization. On the basis of their electrophysiological and pharmacological properties, approximately 80% of DRN neurons were classified as putative 5-HT-containing neurons and ghrelin depolarized 75% of them. These results suggest that DRN neurons, especially 5-HT-containing neurons, might be involved in the neural mechanisms through which ghrelin participates in the development and/or regulation of feeding behavior, sleep-wake states and depressive-like symptoms.

Study Information

Provider

pubmed

Year

2011

Date

2011-07-07T00:00:00.000Z

DOI

10.1016/j.peptides.2011.07.001

Citations

19

References

55